| answer text |
<p>NHS England works in partnership with local commissioners and providers to ensure
people with long-term conditions, such as hidradenitis suppurativa (HS), are supported
to live healthily and independently and are empowered to take better control over
the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with
HS can be managed through routine access to primary and secondary care, including
dermatology clinics, which is responsibility of the local National Health Service
commissioners. Treatment and management of the condition involves antibiotics, antiseptic
washes and immunosuppressive treatments such as steroids or ciclosporin, which a general
practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with
the more serious forms of HS, referral to a specialised dermatology service may be
appropriate. NHS England commissions services for people with rare and complex skin
conditions, including HS, and has set out what providers must have in place in order
to offer specialist dermatology care. This supports equity of access to a high quality
service for patients wherever they live. These services may provide more intensive
therapies with the involvement of a range of health and care professionals, subject
to a patient’s needs. More information can be found by viewing the specialised dermatology
service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf"
target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p>
</p>
|
|
